BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16121665)

  • 1. [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].
    de Bruin JH; Kievit W; Ligtenberg MJ; Nagengast FM; Adang EM; Ruers TJ; Kleibeuker JH; Sijmons RH; van Krieken JH; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1792-8. PubMed ID: 16121665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
    Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
    Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recognising hereditary non-polyposis colorectal cancer without a clear family history].
    de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
    Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to identification of HNPCC suspected patients in Slovak population.
    Fridrichová I; Ilencíková D; Friedl W; Hlavcák P; Skorvaga M; Krizan P; Pálaj J; Pirsel M; Farkasová E; Bartosová Z
    Neoplasma; 2000; 47(4):219-26. PubMed ID: 11043825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
    Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
    J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis.
    Kievit W; de Bruin JH; Adang EM; Ligtenberg MJ; Nagengast FM; van Krieken JH; Hoogerbrugge N
    Clin Genet; 2004 Apr; 65(4):308-16. PubMed ID: 15025724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of a new strategy to identify HNPCC patients.
    Kievit W; de Bruin JH; Adang EM; Severens JL; Kleibeuker JH; Sijmons RH; Ruers TJ; Nagengast FM; Vasen HF; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
    Gut; 2005 Jan; 54(1):97-102. PubMed ID: 15591512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.
    De Bruin JH; Ligtenberg MJ; Nagengast FM; Adang EM; Van Krieken JH; Hoogerbrugge N
    Scand J Gastroenterol Suppl; 2006; (243):146-52. PubMed ID: 16782634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rapid microsatellite analysis of paraffin-embedded specimens in screening for hereditary nonpolyposis colorectal cancer.
    Raedle J; Brieger A; Trojan J; Hardt T; Herrmann G; Zeuzem S
    Mod Pathol; 1999 May; 12(5):485-91. PubMed ID: 10349986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
    Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
    Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
    Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
    J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC).
    González-Aguilera JJ; Nejda N; Fernández FJ; Medina V; González-Hermoso F; Barrios Y; Moreno Azcoita M; Fernández-Peralta AM
    Am J Clin Oncol; 2003 Aug; 26(4):386-91. PubMed ID: 12902892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal adenomas in young patients: microsatellite instability is not a useful marker to detect new cases of Lynch syndrome.
    Ferreira S; Claro I; Lage P; Filipe B; Fonseca R; Sousa R; Francisco I; Chaves P; Albuquerque C; Leitão CN
    Dis Colon Rectum; 2008 Jun; 51(6):909-15. PubMed ID: 18306971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.